Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AVITA MedicalRCEL +6.41%73 1-Year Share Buyback Ratio is -16.20 as of Jun. 2026. GuruFocus rates RCEL with a GF Score™ of 73/100 and a GF Value™ of $10.37 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 548 Medical Devices & Instruments companies, AVITA Medical ranks worse than 72.26% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. AVITA Medical's current 1-Year Share Buyback Ratio was -16.20%.
RCEL's 1-Year Share Buyback Ratio is ranked worse than 72.26% of 548
companies
in the Medical Devices & Instruments industry
Industry Median: -2.75
vs RCEL: -16.20
AVITA Medical (NAS:RCEL) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
AVITA Medical 1-Year Share Buyback Ratio Related Terms
RCEL vs TMCI, VMD, TLSI: 1-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, AVITA Medical's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical 1-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where AVITA Medical's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -16.20 mean?
AVITA Medical (RCEL) has a 1-Year Share Buyback Ratio of -16.20 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for AVITA Medical and its competitors. According to the industry distribution chart, AVITA Medical ranks #396 out of 548 companies in the Medical Devices & Instruments industry, placing it in the top 72.3%.
Is AVITA Medical's 1-Year Share Buyback Ratio too high?
AVITA Medical's current 1-Year Share Buyback Ratio is -16.20. Based on the distribution chart, AVITA Medical ranks #396 out of 548 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AVITA Medical has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AVITA Medical's 1-Year Share Buyback Ratio compare to TMCI and VMD?
According to the Medical Devices & Instruments industry distribution chart, AVITA Medical ranks #396 out of 548 companies for 1-Year Share Buyback Ratio. This places AVITA Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 1-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for AVITA Medical and its competitors. AVITA Medical's current 1-Year Share Buyback Ratio is -16.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVITA Medical stock overvalued right now?
Based on GuruFocus' analysis, AVITA Medical (RCEL) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.37, compared to a current price of $11.54 — trading 11.2% above its estimated fair value. The current 1-Year Share Buyback Ratio is -16.20. AVITA Medical's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For AVITA Medical (RCEL), the current 1-Year Share Buyback Ratio is -16.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AVITA Medical (RCEL) Overvalued in 2026?
Based on GuruFocus' analysis, AVITA Medical stock appears to be overvalued.
The current stock price of $11.54 is trading 11.2% above its estimated GF Value™ of $10.37.
GuruFocus considers AVITA Medical to be Modestly Overvalued.
Key valuation signals for RCEL:
1-Year Share Buyback Ratio: -16.20
GF Value™: $10.37 vs. price of $11.54 (11.2% above fair value)
No single metric tells the full story. See the RCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AVITA Medical Inc. is a commercial-stage regenerative medicine company focused on treatments for skin restoration and wound healing. Its lead product, the RECELL System, is a point-of-care device that produces Spray-On Skin Cells from a small sample of a patient's own skin, used to treat thermal burns and other skin defects while reducing the need for donor skin grafts. The system is approved in the United States for adult and pediatric burn patients and for soft tissue reconstruction, and is used across many U.S. burn centers. AVITA also develops related products for vitiligo and other dermatology applications. The company generates revenue primarily through sales of RECELL devices and associated kits, mainly in the United States, with additional commercial activity in selected international markets. It is headquartered in Valencia, California.
73GF Score
Get the complete analysis for RCEL
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RCEL has been successfully added to your 
